Lindbrook Capital’s General Moly, Inc. GMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-505,000
Closed -$101K 1908
2020
Q2
$101K Hold
505,000
0.03% 204
2020
Q1
$81K Hold
505,000
0.03% 217
2019
Q4
$115K Buy
505,000
+75,000
+17% +$19.5K 0.04% 223
2019
Q3
$112K Buy
430,000
+172,411
+67% +$43.1K 0.04% 215
2019
Q2
$90K Buy
257,589
+252,589
+5,052% +$72.5K 0.03% 250
2019
Q1
$1K Hold
5,000
﹤0.01% 1371
2018
Q4
$1K Buy
+5,000
New +$1.14K ﹤0.01% 1327

Other funds holding GMO

Lindbrook Capital's GMO Position: Q3 2020 in Review

Lindbrook Capital sold out of General Moly, Inc. (GMO) in Q3 2020, closing a stake of 505,000 shares — an estimated $101K sold.

Lindbrook Capital first reported a position in GMO in Q4 2018 and held it in 7 quarters. The position peaked at $115K in Q4 2019. 31 funds tracked by Wall St. Rank hold GMO as of Q3 2020.

  • Lindbrook Capital reported no remaining General Moly, Inc. position as of Q3 2020 after selling out during the quarter.
  • Lindbrook Capital sold 505,000 General Moly, Inc. shares in Q3 2020, an estimated $101K.
  • Lindbrook Capital first reported a position in General Moly, Inc. in Q4 2018 and held it in 7 quarters.
  • Lindbrook Capital's General Moly, Inc. position peaked at $115K in Q4 2019.
  • 31 funds tracked by Wall St. Rank held General Moly, Inc. as of Q3 2020.

Based on Lindbrook Capital's 13F filing for Q3 2020, filed 3 Nov 2020.